A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma

S Halford, D Yip, C Karapetis, A Strickland, A. Steger, H T Khawaja, P Harper

    Research output: Contribution to journalArticlepeer-review

    50 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1399-1402
    Number of pages4
    JournalAnnals of Oncology
    Issue number10
    Publication statusPublished - 2001

    Cite this